A case of butane hash oil (marijuana wax)–induced psychosis

Substance Abuse

Volumn 37, Issue 3, 2016, Pages 384-386

  Keller, Corey J ^a,b   Chen, Evan C ^a,b   Brodsky, Kimberly ^a,b   Yoon, Jong H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Butane hash oil; cannabis; marijuana; psychosis; THC; wax

Indexed keywords

CANNABIS;

ADULT; CASE REPORT; HUMAN; MALE; PSYCHOSIS;

ADULT; CANNABIS; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84979018659     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2016.1141153     Document Type: Article

References (17)

1. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health:Summary of National Findings Rockville, MD:Substance Abuse and Mental Health Services Administration; 2014. NSDUH Series H-48, HHS Publication No. (SMA) 14–4863.
2. M.Loflin, M.Earleywine. A new method of cannabis ingestion:the dangers of dabs?. Addict Behav. 2014;39:1430–1433.
3. 9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci. 2010;55:1209–1217.
4. What You Should Know About Marijuana Concentrates. US Drug Enforcement Administration Web site.http://www.dea.gov/pr/multimedia-library/publications/marijuana-concentrates.pdf. Published December 2014. Accessed August31, 2015.
5. D.C.D'Souza, E.Perry, L.MacDougall, Y.Ammerman, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals:implications for psychosis. Neuropsychopharmacology 2004;29:1558–1572.
6. P.D.Morrison, V.Zois, D.A.McKeown, et al. The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009;39:1607–1616.
7. A.Paparelli, M.Di Forti, P.D.Morrison, R.M.Murray. Drug-induced psychosis:how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front Behav Neurosci. 2011;5:1–9.
8. J.M.Stogner, B.L.Miller. The dabbing dilemma:a call for research on butane hash oil and other alternate forms of cannabis use. Subst Abus. 2015 Aug. [Epub ahead of print].
9. C.Doan. Officials warn of dangers associated with earwax marijuana. KCRA News Web site. http://www.kcra.com/news/officials-warn-of-dangers-associated-with-earwax-marijuana/23041300. Published November 18, 2013. Accessed August31, 2015.
10. C.R.Murphy, G.Martz. Colorado marijuana businesses embrace new drug at center of DEA crackdown in California. ABC News Web site. http://abcnews.go.com/US/colo-marijuana-businesses-embrace-drug-center-dea-crackdown/story?id=22686105. Published February 26, 2014. Accessed August31, 2015.
11. J.Copeland, W.Swift. Cannabis use disorder:epidemiology and management. Int Rev Psychiatr. 2009;21:96–103.
12. A.S.David, M.Prince. Psychosis following head injury:a critical review. J Neurol Neurosurg Psychiatry 2005;76(Suppl 1):i53–i60.
13. D.C.Fujii. Psychotic disorder due to traumatic brain injury:analysis of case studies in the literature. J Neuropsychiatry Clin Neurosci. 2012;24:278–289.
14. M.E.Shenton, H.M.Hamoda, J.S.Schneiderman, et al. A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imaging Behav. 2012;6:137–192.
15. L.Zuurman, P.C.Passier, M.L.de Kam, H.J.Kleijn, A.F.Cohen, J.M.Van Gerven. Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers. J Psychopharmacol. 2010;24:1689–1696.
16. M.Di Forti, A.Marconi, E.Carra, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis:a case-control study. Lancet. 2015;2:233–238.
17. M.Di Forti, C.Morgan, P.Dazzan, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009;195:488–491.